1. Home
  2. RVMD vs TSN Comparison

RVMD vs TSN Comparison

Compare RVMD & TSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

HOLD

Current Price

$148.00

Market Cap

19.2B

Sector

Health Care

ML Signal

HOLD

Logo Tyson Foods Inc.

TSN

Tyson Foods Inc.

HOLD

Current Price

$64.78

Market Cap

21.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVMD
TSN
Founded
2014
1935
Country
United States
United States
Employees
883
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Meat/Poultry/Fish
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
19.2B
21.6B
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
RVMD
TSN
Price
$148.00
$64.78
Analyst Decision
Strong Buy
Buy
Analyst Count
19
10
Target Price
$135.05
$66.90
AVG Volume (30 Days)
3.0M
2.3M
Earning Date
05-06-2026
05-04-2026
Dividend Yield
N/A
3.19%
EPS Growth
N/A
N/A
EPS
N/A
0.24
Revenue
N/A
$54,441,000,000.00
Revenue This Year
N/A
$5.63
Revenue Next Year
$411.49
$1.13
P/E Ratio
N/A
$265.94
Revenue Growth
N/A
2.12
52 Week Low
$34.00
$50.56
52 Week High
$155.70
$66.24

Technical Indicators

Market Signals
Indicator
RVMD
TSN
Relative Strength Index (RSI) 83.31 57.15
Support Level $93.39 $61.99
Resistance Level N/A $64.93
Average True Range (ATR) 5.24 1.13
MACD 6.48 0.02
Stochastic Oscillator 90.61 70.38

Price Performance

Historical Comparison
RVMD
TSN

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

About TSN Tyson Foods Inc.

Tyson Foods is a protein-focused food producer, selling raw chicken, beef, pork, and prepared foods. Chicken and beef are its two largest segments, composing about 40% and 30% of sales, respectively. Prepared foods constituted 18% of fiscal 2025 sales and include brands like Tyson, Jimmy Dean, Hillshire Farm, Ball Park, and Sara Lee. However, most of these are in product categories rife with competition where Tyson does not have a massive market share lead. Tyson sells some products overseas, but the international segment accounts for just 4% of total revenue. The company is an active acquirer, with more recent years' purchases focused on international and food-service markets.

Share on Social Networks: